地西他滨联合常规化疗方案对骨髓增生异常综合征的临床疗效观察  

Clinical Observation of Decitabine Combined with Conventional Chemotherapy Regimen on Myelodysplastic Syndrome

作　　者：陈艳红[1] 叶永斌[1] 许晓军[1] 

机构地区：[1]中山市人民医院血液内科,中山528400

出　　处：《数理医药学杂志》2017年第7期1035-1036,共2页Journal of Mathematical Medicine

基　　金：广东省中山市科技局课题(编号:2014A1FC061)

摘　　要：目的:探究地西他滨联合常规化疗方案对骨髓增生异常综合征的临床疗效观察。方法:选择某院接治的骨髓增生异常综合征患者60例为研究对象,对照组与观察组各30例,比较两组的临床疗效结果。结果:通过两组患者治疗前后发现,两组差异具有统计学意义。结论:应用地西他滨联合常规化疗方案治疗骨髓增生异常综合征具有疗效好的优点,值得广泛采用。Objective：To investigate the clinical effect of decitabine combined with conventional chemotherapy regimen on myelodysplastic syndrome.Methods：60 patients with myelodysplastic syndromes were selected as the study subjects,with 30 cases in the control group and the observation group respectively.Results：Before and after treatment,the difference between the two groups was statistically significant.Conclusion：The application of decitabine combined with conventional chemotherapy in the treatment of myelodysplastic syndromes has the advantages of good curative effect and is worthy of widely application.

关 键 词：地西他滨 常规化疗 骨髓增生异常综合征 疗效观察 

分 类 号：R551.3[医药卫生—血液循环系统疾病]